GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sarepta Therapeutics Inc (STU:AB3A) » Definitions » Change In Prepaid Assets

Sarepta Therapeutics (STU:AB3A) Change In Prepaid Assets : €-133 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sarepta Therapeutics Change In Prepaid Assets?

Sarepta Therapeutics's Change In Prepaid Assets for the quarter that ended in Mar. 2024 was €-133 Mil. It means Sarepta Therapeutics's Prepaid Assets declined by €133 Mil from Dec. 2023 to Mar. 2024 .

Sarepta Therapeutics's Change In Prepaid Assets for the fiscal year that ended in Dec. 2023 was €0 Mil. It means Sarepta Therapeutics's Prepaid Assets stayed the same from Dec. 2022 to Dec. 2023 .

Sarepta Therapeutics Change In Prepaid Assets Historical Data

The historical data trend for Sarepta Therapeutics's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sarepta Therapeutics Change In Prepaid Assets Chart

Sarepta Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Prepaid Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sarepta Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.99 - - - -133.44

Sarepta Therapeutics Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-133 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sarepta Therapeutics Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Sarepta Therapeutics's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sarepta Therapeutics (STU:AB3A) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sarepta Therapeutics Inc (STU:AB3A) » Definitions » Change In Prepaid Assets
Comparable Companies
RPRX UTHR TECH INCY BMRN ROIV LEGN CERE PCVX ASND OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
SRPT:USA S1RP34:Brazil
Address
215 First Street, Suite 415, Cambridge, MA, USA, 02142
Website
https://www.sarepta.com
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's strategy involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Most of Sarepta's product candidates are at an early stage of development.

Sarepta Therapeutics (STU:AB3A) Headlines

No Headlines